Vitamin D and the occurrence of depression: Causal association or circumstantial evidence?

Nutrition Reviews

Volumn 67, Issue 8, 2009, Pages 481-492

  Bertone Johnson, Elizabeth R ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

25 hydroxyvitamin D; Depression; Review; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 3,4 DIHYDROXYPHENYLACETIC ACID; 7 DEHYDROCHOLESTEROL; CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; MONOAMINE OXIDASE INHIBITOR; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VITAMIN D;

BECK DEPRESSION INVENTORY; BRAIN DEVELOPMENT; CLINICAL TRIAL; DEPRESSION; DIETARY INTAKE; DRUG DOSE COMPARISON; EVIDENCE BASED MEDICINE; FIBROMYALGIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MOOD; NONHUMAN; PATHOPHYSIOLOGY; PHOTOTHERAPY; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; REVIEW; SEASONAL AFFECTIVE DISORDER; SUN EXPOSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANIMALS; BIOGENIC MONOAMINES; BRAIN; DEPRESSION; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; PREMENSTRUAL SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, CALCITRIOL; SEASONAL AFFECTIVE DISORDER; STRESS, PSYCHOLOGICAL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77954760546     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2009.00220.x     Document Type: Review

References (70)

1. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med. 2008;263:599-609.
2. Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88(suppl);S491- S499.
3. Holick MF. The vitamin D epidemic and its health consequences. J Nutr. 2005;135:2739S-2748S.
4. Vieth R, Bischoff-Ferrari H, Boucher BJ, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr. 2007;85:649-650.
5. Holick MF. Vitamin D: a D-Lightful health perspective. Nutr Rev. 2008;66(Suppl 2):S182-S194.
6. th ed: DSM-IV. Washington, DC: Author; 1994.
7. Cerdá M, Sagdeo A, Galea S. Comorbid forms of psychopathology: key patterns and future research directions. Epidemiol Rev. 2008;30:155-177.
8. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008;358:55-68.
9. Ruhé HG, Mason NS, Schene AH. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry. 2007;12:331-359.
10. Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry. 2007;64:327-337.
11. Eisch AJ, Cameron HA, Encinas JM, Meltzer LA, Ming GL, Overstreet-Wadiche LS. Adult neurogenesis, mental health, and mental illness: hope or hype?. J Neurosci. 2008; 28:11785-11791.
12. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002;13:100-105.
13. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29:21-30.
14. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct. 2008;213:93-118.
15. 3-1alpha-hydroxylase. J Clin Endocrinol Metab. 2001;86:888-894.
16. Gascon-Barré M, Huet PM. Apparent [3H]1,25- dihydroxyvitamin D3 uptake by canine and rodent brain. Am J Physiol. 1983;244:E266-E271.
17. Pardridge WM, Sakiyama R, Coty WA. Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier. J Neurochem. 1985;44:1138-1141.
18. Newmark HL, Newmark J. Vitamin D and Parkinson's disease - a hypothesis. Mov Disord. 2007;22:461-468.
19. McGrath JJ, Feron FP, Burne THJ, Mackay-Sim A, Eyles DW. Vitamin D3- implications for brain development. J Steroid Biochem Mol Biol. 2004:89-90;557-560.
20. Féron F, Burne THJ, Brown J, et al. Developmental vitamin D3 deficiency alters the adult rat brain. Brain Res Bull. 2005;65:141-148.
21. Handoko HY, Nancarrow DJ, Mowry BJ, McGrath JJ. Polymorphisms in the vitamin D receptor and their associations with risk of schizophrenia and selected anthropometric measures. Am J Hum Biol. 2006;18:414-417.
22. Minasyan A, Keisala T, Lou YR, Kalueff AV, Tuohimaa P. Neophobia, sensory and cognitive functions, and hedonic responses in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol. 2007;104:274-280.
23. Kalueff AV, Keisala T, Minasyan A, Kuuslahti M, Miettinen S, Tuohimaa P. Behavioral anomalies in mice evoked by "Tokyo" disruption of the vitamin D receptor gene. Neurosci Res. 2006;54:254-260.
24. Burne THJ, McGrath JJ, Eyles DW, Mackay-Sim A. Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res. 2005;157:299-308.
25. Burne THJ, Johnston ANB, McGrath JJ, Mackay-Sim A. Swimming behavior and post-swimming activity in vitamin D receptor knockout mice. Brain Res Bull. 2006;69:74-78.
26. Harms LR, Eyles DW, McGrath JJ, Mackay-Smith A, Burne THJ. Developmental vitamin D deficiency alters adult behavior in 129/SvJ and C57BL/6J mice. Behav Brain Res. 2008;187:343-350.
27. Cass WA, Smith MP, Peters LE. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine. Ann NY Acad Sci. 2006;1074:261-271.
28. Smith MP, Fletcher-Turner A, Yurek DM, Cass WA. Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochem Res. 2006;31:533-539.
29. Baksi SN, Hughes MJ. Chronic vitamin D deficiency in the weanling rat alters catecholamine metabolism in the cortex. Brain Res. 1982;242:387-390.
30. Obradovic D, Gronemeyer H, Lutz B, Rein T. Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem. 2006;96:500-509.
31. Schneider B,Weber B, Frensch A, Stein J, Fritze J. VitamIn D in schizophrenia, major depression and alcoholism. J Neural Transm. 2000;107:839-842.
32. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry. 2006;14:1032-1040.
33. Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study. J Neurol. 2006;253:464-470.
34. Eskandari F, Martinez PE, Torvik S, et al. Low bone mass in premenopausal women with depression. Arch Intern Med. 2007;167:2329-2336.
35. Hoogendijk WJG, Lips P, Dik MG, Deeg DJ, Beekman ATF, Penninx BWJH. Depression is associated with decreased 25-hydroxyvitmain D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry. 2008;65:508-512.
36. Pan A, Lu L, Franco OH, Yu Z, Li H, Lin X. Association between depressive symptoms and 25-hydroxyvitamin D in middleaged and elderly Chinese. J Affect Disord. 2009;doi:10.1016/j.jad2009.02.002
37. Herrán A, Amado JA, García-Unzueta MT, Vázquez- Barquero JL, Perera L, Gonzáles-Macías J. Increased bone remodeling in first-episode major depressive disorder. Psychosom Med. 2000;62:779-782.
38. Michelson D, Stratakis C, Hill L, et al. Bone mineral density in women with depression. N Engl J Med. 1996;335:1176-1181.
39. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:225-236.
40. Brot C, Jørgensen NR, Sørensen OH. The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr. 1999;53:920-926.
41. Gerdheim P, Ringsberg KAM, Obrant KJ, Akesson K. Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective populationbased OPRA Study of Elderly Women. Osteoporos Int. 2005;16:1425-1431.
42. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease and osteoporosis. Am J Clin Nutr. 2004;79:362-371.
43. Hintzpeter B, Mensink GBM, Thierfelder W, Müller MJ, Scheidt-Nave C. Vitamin D status and health correlated among German adults. Eur J Clin Nutr. 2008;62:1079-1089.
44. Santori D, Ceccanti M, Diacinti D, et al. Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol. J Endocrinol Invest. 2008;31:321-326.
45. Bjerkeset O, Romundstad P, Evans J, Gunnell D. Association of adult body mass index and height with anxiety, depression, and suicide in the general population. The HUNT study. Am J Epidemiol. 2008;167:193-202.
46. Pasco JA, Williams LJ, Jacka FN, et al. Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br J Psychiatry. 2008;193:322-326.
47. Roberts RE, Kaplan GA, Sherma SJ, Strawbridge WJ. Does growing old increase the risk for depression?. Am J Psychiatry. 1997;154:1384-1390.
48. Galper DI, Trivedi MH, Barlow CE, Dunn AL, Kampert JB. Inverse association between physical inactivity and mental health in men and women. Med Sci Sports Exerc. 2006; 38:173-178.
49. Jané-Llopis E, Matytsina I. Mental health and alcohol, drug and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev. 2006;25:515-536.
50. Lurie SJ, Gawinski B, Pierce D, Rousseau SJ. Seasonal affective disorder. Am Fam Physician. 2006;74:1521-1524.
51. Stumpf WE, Privette TH. Light, vitamin D and psychiatry: role of 1,25-dihydroxyvitamin D3 (soltiol) in etiology and therapy of seasonal affective disorder and other mental processes. Psychopharmacology. 1989;97:285-294.
52. Vieth R, Kimball S, Hu A,Walfish PG. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J. 2004;3:8.
53. Gloth FM III, Alam W, Hollis B. Vitamin D vs. broad spectrum Phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging. 1999;3:5-7.
54. Lansdowne ATG, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology. 1998; 135:319-323.
55. Harris S, Dawson-Hughes B. Seasonal mood changes in 250 normal women. Psychiatry Res. 1993;49:77-87.
56. Dumville JC, Miles JV, Porthouse J, et al. Can vitamin D supplementation prevent winter-time blues? Arandomised trial among older women. J Nutr Health Aging. 2006;10:151-153.
57. Partonen T, Vakkuri O, Lamberg-Allardt C, Lönnqvist J. Effects of bright light on sleepiness, melatonin, and 24-hydroxyvitamin D3 in winter seasonal affective disorder. Biol Psychiatry. 1996;39:865-872.
58. 3 levels in seasonal affective disorder: effects of light. Psychopharmacology. 1994;116:515-516.
59. American College of Obstetricians and Gynecologists Practice Bulletin. Clinical management guidelines for obstetriciansgynecologists. Number 15, April 2000. Premenstrual syndrome. Obstet Gynecol. 2000;95:1-9.
60. Mortola JFJr. Issues in the diagnosis and research of premenstrual syndrome. Clin Obstet Gynecol. 1992;35:587-598.
61. Johnson SR. The epidemiology and social impact of premenstrual symptoms. Clin Obstet Gynecol. 1987;30:367-376.
62. Mortola JF, Girton L, Beck L, Yen SS. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol. 1990;76:302-307.
63. Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology. 2003;28:25-37.
64. Thys-Jacobs S. Micronutrients and the premenstrual syndrome: the case for calcium. J AmColl Nutr. 2000;19:220-227.
65. Thys-Jacobs S, Alvir MJ. Calcium-regulating hormones across the menstrual cycle: evidence of a secondary hyperparathyroidism in women with PMS. J Clin Endocrinol Metab. 1995;80:2227-2232.
66. Thys-Jacobs S, McMahon D, Bilezikian JP. Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder. J Clin Endocrinol Metab. 2007;92:2952-2959.
67. Bertone-Johnson ER, Hankinson SE, Bendich A, Johnson SR, Willett WC, Manson JE. Calcium and vitamin D intake and risk of incident premenstrual syndrome. Arch Intern Med. 2005;165:1246-1252.
68. Ablin J, Neumann L, Buskila D. Pathogenesis of fibromyalgia - a review. Joint Bone Spine. 2008;75:273-279.
69. Bradley LA. Pathophysiologic mechanisms of fibromyalgia and its related disorders. J Clin Psychiatry. 2008; 69(Suppl):S6-S13.
70. Armstrong DJ, Meenagh GK, Bickle I, Lee AS, Curran ES, Finch MB. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol. 2007;26:551-554.